<?xml version='1.0' encoding='utf-8'?>
<document id="27042808"><sentence text="Stability behaviour of antiretroviral drugs and their combinations. 2: Characterization of interaction products of lamivudine and tenofovir disoproxil fumarate by mass and NMR spectrometry."><entity charOffset="115-125" id="DDI-PubMed.27042808.s1.e0" text="lamivudine" /><entity charOffset="130-159" id="DDI-PubMed.27042808.s1.e1" text="tenofovir disoproxil fumarate" /><pair ddi="false" e1="DDI-PubMed.27042808.s1.e0" e2="DDI-PubMed.27042808.s1.e0" /><pair ddi="false" e1="DDI-PubMed.27042808.s1.e0" e2="DDI-PubMed.27042808.s1.e1" /></sentence><sentence text="This study focused on drug-drug interaction behaviour among lamivudine (3TC) and tenofovir disoproxil fumarate (TDF), the two anti-retroviral drugs"><entity charOffset="60-70" id="DDI-PubMed.27042808.s2.e0" text="lamivudine" /><entity charOffset="72-75" id="DDI-PubMed.27042808.s2.e1" text="3TC" /><entity charOffset="81-110" id="DDI-PubMed.27042808.s2.e2" text="tenofovir disoproxil fumarate" /><entity charOffset="112-115" id="DDI-PubMed.27042808.s2.e3" text="TDF" /><pair ddi="false" e1="DDI-PubMed.27042808.s2.e0" e2="DDI-PubMed.27042808.s2.e0" /><pair ddi="false" e1="DDI-PubMed.27042808.s2.e0" e2="DDI-PubMed.27042808.s2.e1" /><pair ddi="false" e1="DDI-PubMed.27042808.s2.e0" e2="DDI-PubMed.27042808.s2.e2" /><pair ddi="false" e1="DDI-PubMed.27042808.s2.e0" e2="DDI-PubMed.27042808.s2.e3" /><pair ddi="false" e1="DDI-PubMed.27042808.s2.e1" e2="DDI-PubMed.27042808.s2.e1" /><pair ddi="false" e1="DDI-PubMed.27042808.s2.e1" e2="DDI-PubMed.27042808.s2.e2" /><pair ddi="false" e1="DDI-PubMed.27042808.s2.e1" e2="DDI-PubMed.27042808.s2.e3" /><pair ddi="false" e1="DDI-PubMed.27042808.s2.e2" e2="DDI-PubMed.27042808.s2.e2" /><pair ddi="false" e1="DDI-PubMed.27042808.s2.e2" e2="DDI-PubMed.27042808.s2.e3" /></sentence><sentence text=" Apart from pre-known degradation products of individual drugs, a total of twelve interaction products were detected by high performance liquid chromatography (HPLC) using a C18 column as the stationary phase, and methanol and ammonium formate in gradient mode as the mobile phase"><entity charOffset="214-222" id="DDI-PubMed.27042808.s3.e0" text="methanol" /><entity charOffset="227-243" id="DDI-PubMed.27042808.s3.e1" text="ammonium formate" /><pair ddi="false" e1="DDI-PubMed.27042808.s3.e0" e2="DDI-PubMed.27042808.s3.e0" /><pair ddi="false" e1="DDI-PubMed.27042808.s3.e0" e2="DDI-PubMed.27042808.s3.e1" /></sentence><sentence text=" The same HPLC method was employed for liquid chromatography-high resolution mass spectrometry (LC-HRMS) and liquid chromatography-multi stage mass spectrometry (LC-MS(n))" /><sentence text=" For the characterization of interaction products, stability samples were subjected to LC-HRMS, LC-MS(n) and online hydrogen/deuterium exchange studies"><entity charOffset="116-124" id="DDI-PubMed.27042808.s5.e0" text="hydrogen" /><entity charOffset="125-134" id="DDI-PubMed.27042808.s5.e1" text="deuterium" /><pair ddi="false" e1="DDI-PubMed.27042808.s5.e0" e2="DDI-PubMed.27042808.s5.e0" /><pair ddi="false" e1="DDI-PubMed.27042808.s5.e0" e2="DDI-PubMed.27042808.s5.e1" /></sentence><sentence text=" Two isomeric interaction products were isolated and subjected to 1D and 2D nuclear magnetic resonance (NMR) studies" /><sentence text=" The collated information was utilized for the characterization of all twelve interaction products of the two drugs" /><sentence text=" Pathway of their formation was also outlined" /><sentence text=" " /></document>